Shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK – Get Free Report) rose 0.4% during trading on Tuesday . The company traded as high as $12.14 and last traded at $12.01. 84,299 shares traded hands during trading, an increase of 194% from the average daily volume of 28,719 shares. The stock had previously closed at $11.96.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.
Read Our Latest Research Report on AFJK
Aimei Health Technology Stock Performance
Aimei Health Technology (NASDAQ:AFJK – Get Free Report) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.03) EPS for the quarter.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. Jane Street Group LLC purchased a new stake in Aimei Health Technology during the 4th quarter worth about $302,000. Geode Capital Management LLC purchased a new position in Aimei Health Technology in the 4th quarter valued at about $413,000. Quarry LP lifted its holdings in Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after purchasing an additional 10,000 shares in the last quarter. Finally, Clear Street Group Inc. boosted its stake in shares of Aimei Health Technology by 36.5% during the 4th quarter. Clear Street Group Inc. now owns 83,337 shares of the company’s stock worth $5,334,000 after purchasing an additional 22,294 shares during the last quarter. 45.58% of the stock is currently owned by hedge funds and other institutional investors.
Aimei Health Technology Company Profile
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.
Further Reading
- Five stocks we like better than Aimei Health Technology
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.
